Correlation Between GlaxoSmithKline PLC and Growth Income
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Growth Income at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Growth Income into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Growth Income Fund, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Growth Income and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Growth Income. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Growth Income.
Diversification Opportunities for GlaxoSmithKline PLC and Growth Income
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Growth is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Growth Income Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Growth Income and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Growth Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Growth Income has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Growth Income go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Growth Income
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 4.21 times less return on investment than Growth Income. In addition to that, GlaxoSmithKline PLC is 1.41 times more volatile than Growth Income Fund. It trades about 0.01 of its total potential returns per unit of risk. Growth Income Fund is currently generating about 0.07 per unit of volatility. If you would invest 2,110 in Growth Income Fund on August 24, 2024 and sell it today you would earn a total of 767.00 from holding Growth Income Fund or generate 36.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Growth Income Fund
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Growth Income |
GlaxoSmithKline PLC and Growth Income Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Growth Income
The main advantage of trading using opposite GlaxoSmithKline PLC and Growth Income positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Growth Income can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Growth Income will offset losses from the drop in Growth Income's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Growth Income vs. American Funds Conservative | Growth Income vs. Evaluator Conservative Rms | Growth Income vs. Massmutual Premier Diversified | Growth Income vs. Western Asset Diversified |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |